Ind-Swift Laboratories Hits 52-Week High of Rs 408: What's Driving the Stock Today

Published: 22 September 2026 at 10:18 AM IST

Ind-Swift Laboratories Share Price rose to Rs 405.70, up 6.33% today, and touched a fresh 52-week high of Rs 408. The company’s market capitalisation stands at Rs 3,244.54 crore.

Ind-Swift Laboratories Share Price moved to Rs 405.70 today, gaining 6.33% from the previous close of Rs 381.55 and touching a fresh 52-week high of Rs 408. The company’s market capitalisation is Rs 3,244.54 crore, placing the move in clear market context. The latest Ind-Swift Laboratories Share Price today update matters because it confirms a new yearly high in regular trading, with the day opening at Rs 373.40 and the session low at Rs 373.35 before the stock finished close to the intraday peak. Univest tracks this move as part of Ind-Swift Laboratories Stock News and Ind-Swift Laboratories Share Price Live coverage. The supplied data confirms the price event, but it does not establish a company-specific catalyst.

Ind-Swift Laboratories Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 405.7
Previous Close	Rs 381.55
Today's Move	+Rs 24.15 (+6.33%)
Open	Rs 373.4
High	Rs 408
Low	Rs 373.35
Turnover	Rs 5.27 crore
Market Capitalisation	Rs 3,244.54 crore

Ind-Swift Laboratories Ltd. (INDSWFTLAB) traded at Rs 405.7 versus the previous close of Rs 381.55, a rise of 6.33%. The stock opened at Rs 373.4, reached a high of Rs 408 and touched a low of Rs 373.35.

Ind-Swift Laboratories Share Price today reflects a session that opened below the previous close, moved through Rs 373.40, and later reached Rs 408 before settling at Rs 405.70. The day change of Rs 24.15 shows a clear upward move against the previous close of Rs 381.55. The spread between the previous close and the 52-week high is narrow because the high printed at Rs 408, which is also the day high. Turnover for the session stood at Rs 5.27 crore. In simple terms, the stock ended the day near its best level and recorded a fresh 52-week peak, which keeps Ind-Swift Laboratories Share Price in focus across Ind-Swift Laboratories Stock News, Ind-Swift Laboratories News Today and Ind-Swift Laboratories Share Price Update coverage.

Ind-Swift Laboratories Ltd. (INDSWFTLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 3,244.54 crore
P/E Ratio	56.35x
P/B Ratio	2.24x
ROE	3.46%
ROCE	4%
EPS	Rs 6.77
Book Value Per Share	Rs 171.98
Dividend Yield	0%

Ind-Swift Laboratories Ltd. (INDSWFTLAB) fundamental metrics show P/E 56.35x, P/B 2.24x, ROE 3.46%, ROCE 4%. These figures provide context only and are not a buy or sell signal.

Ind-Swift Laboratories Ltd. has a market capitalisation of Rs 3244.54 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 56.35x, P/B at 2.24x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 3.46% and ROCE of 4%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 6.77, book value per share of Rs 171.98, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P/E of 32.39x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	56.35x
Benchmark Median P/E	32.39x
Benchmark Average P/E	49.47x
Benchmark P/E Range	3.37x to 747.32x
Company P/B Ratio	2.24x
Benchmark Median P/B	3.03x
Company ROE	3.46%
Benchmark Median ROE	11.78%
Company ROCE	4%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 3,244.54 crore
Benchmark Median Market Cap	Rs 729.99 crore

Ind-Swift Laboratories Ltd. (INDSWFTLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P/E ratio of 56.35x, which is above the benchmark median of 32.39x, a difference of +73.97%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROE of 3.46%, which is below the benchmark median of 11.78%, a difference of -70.63%. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a ROCE of 4%, which is below the benchmark median of 13.65%, a difference of -70.7%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Advanced Enzyme Technologies Ltd.	ADVENZYMES	3,226.59	19.84	1.98	11.43	15.27
Kwality Pharmaceuticals Ltd.	KPL	3,606.14	49.12	11.17	22.67	24.01
Unichem Laboratories Ltd.	UNICHEMLAB	3,840.63	12.47	1.38	9.81	10.68
Dishman Carbogen Amcis Ltd.	DCAL	2,672.37	165.22	0.4	1.56	3.21
Aarti Drugs Ltd.	AARTIDRUGS	3,940.58	20.79	2.49	13.36	12.04

Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a P/E ratio of 56.35x compared with the displayed peer median of 20.79x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 3.46% compares with a peer median of 11.43% across the companies shown in the table. ROCE stood at 4% versus the displayed peer median of 12.04%, providing a capital-efficiency comparison. Ind-Swift Laboratories Ltd. (INDSWFTLAB) has a market capitalisation of Rs 3,244.54 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Ind-Swift Laboratories

• Ind-Swift Laboratories Share Price hit a fresh 52-week high of Rs 408 and closed at Rs 405.70.
• The stock rose Rs 24.15, or 6.33%, from the previous close of Rs 381.55.
• Market capitalisation stands at Rs 3,244.54 crore.
• P/E is 56.35, P/B is 2.24, ROE is 3.46% and ROCE is 4%.
• Revenue and net profit for Jun 2026 are higher than the year-ago quarter in the supplied data.

About Ind-Swift Laboratories

Ind-Swift Laboratories Ltd. is classified in Healthcare and Pharmaceuticals & Drugs. This article uses only the supplied market and financial figures, including the company’s share price, market capitalisation, valuation ratios and reported quarterly revenue and net profit. For readers tracking Ind-Swift Laboratories Company News, the current filing set offers a clear snapshot of where the stock stands in the market. Univest keeps the company page updated so users can revisit Ind-Swift Laboratories Share Price, Ind-Swift Laboratories Share Price Today and Ind-Swift Laboratories Latest News in one place.

Track Ind-Swift Laboratories Share Price on Univest

Use Ind-Swift Laboratories Ltd. (INDSWFTLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

Track Ind-Swift Laboratories Share Price on Univest for live price updates, fundamental ratios, 52-week levels, company news, valuation checks and market insights. Univest also helps users follow Ind-Swift Laboratories Stock Analysis, Ind-Swift Laboratories Share Price Live and Ind-Swift Laboratories Shareholding Pattern on the stock page.

Frequently Asked Questions

Why did Ind-Swift Laboratories Share Price hit a fresh 52-week high?

Ans. The supplied data confirms that Ind-Swift Laboratories Share Price touched Rs 408, a fresh 52-week high, and closed at Rs 405.70. The dataset does not establish a company-specific catalyst for the move.

What is the current Ind-Swift Laboratories Share Price today?

Ans. Ind-Swift Laboratories Share Price today is Rs 405.70, up Rs 24.15 or 6.33% from the previous close of Rs 381.55. The stock also marked a fresh yearly high during the session.

What is the 52-week high for Ind-Swift Laboratories?

Ans. The 52-week high for Ind-Swift Laboratories is Rs 408. The stock reached that level in the latest session and ended close to the peak at Rs 405.70. The stock moved 6.33% during the session.

What does the market capitalisation of Ind-Swift Laboratories show?

Ans. Ind-Swift Laboratories has a market capitalisation of Rs 3,244.54 crore. Market capitalisation reflects company size in market terms, while valuation and profitability require separate review of P/E, P/B, ROE and ROCE.

How does Ind-Swift Laboratories compare on valuation?

Ans. Ind-Swift Laboratories Share Price corresponds to a P/E of 56.35 and a P/B of 2.24. In the supplied industry benchmark, that P/E is above the median and average, while the P/B is below both.

What do ROE and ROCE mean for Ind-Swift Laboratories?

Ans. ROE is 3.46% and ROCE is 4% for Ind-Swift Laboratories. Both are below the supplied industry medians, so the figures provide a cautious profitability backdrop for the current Ind-Swift Laboratories Share Price.

What earnings data is available for Ind-Swift Laboratories?

Ans. The supplied data shows Jun 2026 revenue of Rs 1,914.54 crore and net profit of Rs 246.84 crore, both above the Jun 2025 figures. EPS is Rs 6.77 and book value is Rs 171.98.

How does Ind-Swift Laboratories compare with peers?

Ans. Among the listed peers, Ind-Swift Laboratories has a market cap close to Advanced Enzyme Technologies and below several others. Its P/E is higher than some peers such as Unichem Laboratories and Aarti Drugs.

Where can I track Ind-Swift Laboratories Share Price and stock news?

Ans. Readers can track Ind-Swift Laboratories Share Price, stock news, valuation ratios, 52-week levels and related market insights on Univest. The stock page keeps the latest company snapshot in one place.